Published in Immunotherapy Weekly, March 12th, 2003
"HSV-1 negative/HSV-2 negative sera (n=32), HSV-1 positive/HSV-2 negative sera (n=30) and sera from HSV-2 culture positive individuals (n=36), collected at least 6 months after culture verified HSV-2 genital infection were examined," researchers in Norway report.
"Cut-off values were determined according to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2003-03-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.